CLINICAL STUDY OF ACETAZOLAMIDE ON CENTRAL SEROUS CHOROIDORETINOPATHY
Fang Xiaoyun; Su Zhaoan; Xuan Mengzheng(Departmetn of Ophthalmology, the Second Affilited Hospital, Zhejiang Medical University)
The authors reported the changes of subjective improvement, corrected visual acuity, ocularfundus and side effects on patients with central serous choroidoretinopathy who had been randomly assigned to receive either oral acetazolamide (20 cases, treatment group) or no acetazolamide (20 cases, control group ). The follow-up Period ranged from 6 to 8 months. The recoveryrates of the two groups within one and a half months were significantly different (P0. 01).The results indicated that acetazolamide might shorten the clinical course of the disease, However,there were no differences in final effect and recurrence rate between two groups. No serious sideeffects of the drug were observed.
【CateGory Index】： R96